Table 3.

Effect of decorporation treatment with diethylenetriaminepentaacetic acid after the inhalation of a poorly soluble plutonium-239 compound or injection into a wound of a soluble compound (1 μCi,) depending on the duration of the treatment

Treatment Duration
	None	14 Days	30 Days	90 Days	120 Days	150 Days	180 Days
Committed effective dose (mSv)
Inhalation	260	152	87	15	8.2	5.7	4.7
Wound	823	199	149	50	29	17	10
Therapeutic efficacy
Inhalation	0	0.42	0.67	0.94	0.97	0.98	0.98
Wound	0	0.76	0.82	0.94	0.97	0.98	0.99

The initiation of treatment was assumed to be 1 h after acute inhalation or injection into the wound. The dose reduction factor was calculated by dividing the committed effective dose absorbed under treatment by the dose without treatment. Efficacy was estimated by subtracting the dose reduction factor from one.